Skip to content

A Phase IV Clinical Trial of Zhenqi Yishen Keli

A Phase IV Clinical Trial of Zhenqi Yishen Keli

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021394
Enrollment
Unknown
Registered
2019-02-18
Start date
2019-02-25
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic glomerulonephritis

Interventions

Case series:Zhenqi Yishen Keli

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Compliance with the diagnostic criteria of chronic glomerulonephritis in Western medicine; (1) 24-hour urinary protein quantification more than 0.3g/24h and less than 3.5g/24h; (2) Latent glomerulonephritis; 2. Compliance with the pattern of deficiency of both qi and yin and accompanying symptoms of damp-heat; 3. Aged 18 to 75, male and female; 4. Informed consent and signed of informed consent forms.

Exclusion criteria

Exclusion criteria: 1. GFR 150 mmHg or diastolic blood pressure > 90 mmHg; 3. Hormone therapy 2 times the reference upper limit), malignant tumors; 8. Patients with allergic constitution or anaphylaxis to the drug or its components; 9. Lactation,pregnancy or have a pregnant plan during the trial; 10. Those who have mental disorders or can not cooperate with investigator to complete the trial; 11. Patients who participated in other clinical studies within the past month; 12. Patients that the investigator believes are not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Quantitative changes of 24-hour urinary protein;

Secondary

MeasureTime frame
Changes of RBC in urine sediment examination;Changes of serum creatinine (Scr);Change rate of eGFR;ChangeofTCM syndrome;Change of single TCM syndrome;

Countries

China

Contacts

Public ContactHongkai Li

Beijing tongrentang co., LTD

eoleyar@163.com+86 010-87632545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026